Furthermore, it has been shown that insulin, a medicine for treating hyperglycemia or diabetes, can attenuate ACE2 expression (Muniyappa and Gubbi, 2020), suggesting that well-controlled glycemia may reduce the risk of COVID-19 infection via decreasing the cellular levels of ACE2. Here, INS is linked to diabetes mellitus.